RecruitingNCT06505577

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

Concordance Between Preoperative Assessments and Pathologic Size Measurements in Breast Cancer: a Prospective Observational Study

Sponsor

Incheon St.Mary's Hospital

Enrollment

600 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Mastectomy Breast Neoplasm Malignant Primary

Summary

Breast cancer, the most prevalent malignancy among women globally, is increasing in incidence. While non-metastatic breast cancer requires surgery, determining the optimal extent of resection remains challenging. Inadequate resection margins necessitate reoperation, leading to increased psychological stress, costs, and potentially compromised cosmetic outcomes and prognosis. Accurate preoperative assessment of resection extent is crucial and involves various factors, including imaging studies, physical examinations, tumor molecular subtypes, and intraductal carcinoma components. This prospective observational study aims to identify and integrate multiple predictive factors to enhance surgical planning and minimize reoperation rates in breast cancer patients.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study compares the tumor size measured on imaging scans before surgery to the actual size measured from the removed tissue after surgery for breast cancer. The goal is to understand how accurate pre-surgical measurements are, which can influence treatment planning. **You may be eligible if...** - You are 19 years or older with a confirmed diagnosis of breast cancer (invasive or in situ) - You are scheduled for surgical removal of the tumor - Pre-operative tumor size measurements are available **You may NOT be eligible if...** - You have recurrent (previously treated) breast cancer - You have inflammatory breast cancer - You did not undergo surgery - Pre-operative tumor size data is incomplete or unavailable Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo additional intervention

All patients are scheduled to undergo standard breast surgery as part of their routine clinical care. No additional interventions are administered specifically for this study.